SANOFI CONSUMER HEALTHCARE INDIA
|
The Current P/S Ratio of SANOFI CONSUMER HEALTHCARE INDIA is 17.83.
Share Price | ₹5,176.6 | Jul 11,2025 |
Market Cap | ₹11,906.2 Cr | |
Sales-TTM | ₹667.6 Cr | TTM-Standalone Results |
Price/Sales | 17.83x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SANOFI CONSUMER HEALTHCARE INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹11,906.2 Cr] as on Jul 11,2025
(/) Sales [ ₹667.6 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 17.83x ]
Thus, for SANOFI CONSUMER HEALTHCARE INDIA , the investors are currently willing to pay '17.83 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SANOFI CONSUMER HEALTHCARE INDIA !
The chart below summarizes the trend in P/S Ratio of SANOFI CONSUMER HEALTHCARE INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of SANOFI CONSUMER HEALTHCARE INDIA
PS Ratio Performance Analysis for SANOFI CONSUMER HEALTHCARE INDIA
- SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio for fiscal years ending Dec2024 to Dec2023 averaged 7.82x.
- SANOFI CONSUMER HEALTHCARE INDIA 's operated at median p/e ratio of 15.64x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio peaked in Dec2024 at 15.64x.
- SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio hit its five-year low in Dec2023 of 0x.
How does SANOFI CONSUMER HEALTHCARE INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SANOFI CONSUMER HEALTHCARE INDIA | 667.6 | 17.83 | 11,906.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 52,578.4 | 7.63 | 401,289.0 |
DIVIS LABORATORIES LTD | 9,360.0 | 19.38 | 181,397.0 |
CIPLA LTD | 27,547.6 | 4.35 | 119,955.0 |
TORRENT PHARMACEUTICALS LTD | 11,516.0 | 9.74 | 112,132.0 |
DR REDDYS LABORATORIES LTD | 32,643.9 | 3.21 | 104,657.0 |
MANKIND PHARMA LTD | 12,279.3 | 8.67 | 106,401.0 |
ZYDUS LIFESCIENCES LTD | 23,241.5 | 4.24 | 98,570.7 |
LUPIN LTD | 22,707.9 | 3.81 | 86,442.7 |
AUROBINDO PHARMA LTD | 31,723.7 | 2.06 | 65,308.2 |
ABBOTT INDIA LTD | 6,409.2 | 11.41 | 73,118.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SANOFI CONSUMER HEALTHCARE INDIA 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.06x |
Max industry PS | 19.38x |
Median industry PS | 7.63x |
Average industry PS | 8.39x |
You may also like the below Video Courses